Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 148 M29 M100 M80 M203 M35 M 418 M Non-Operating Income, Total 26 M24 M26 M26 M23 M25 M 100 M Interest expense, net of interest capitalized 312 M317 M320 M323 M322 M326 M 1.29 B Non-Operating Income, excl. Interest Expenses -286 M-293 M-294 M-297 M-299 M-301 M -1.19 B Unusual income/expense —————— — Pretax income 275 M214 M263 M249 M296 M196 M 1 B Equity in earnings —————— — Taxes 62 M47 M64 M45 M70 M44 M 223 M Non-controlling/minority interest —————— — After tax other income/expense 1 M02 M1 M3 M— — Net income before discontinued operations 213 M167 M199 M204 M226 M152 M 781 M Discontinued operations —————— — Net income 213 M167 M199 M204 M226 M152 M 781 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 213 M167 M199 M204 M226 M152 M 781 M Basic earnings per share (Basic EPS) 1.791.41.671.731.931.32 6.65 Diluted earnings per share (Diluted EPS) 1.781.41.671.711.931.32 6.63 Average basic shares outstanding 119.4 M118.95 M118.76 M118.66 M116.72 M116.03 M — Diluted shares outstanding 119.97 M119.39 M119.42 M119.27 M117.27 M116.51 M — EBITDA —————— — EBIT -164 M-288 M-220 M-243 M-119 M-291 M -873 M Cost of revenue 505 M565 M536 M589 M517 M654 M 2.3 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —